BioRestorative Therapies, Inc. Common Stock (NV)

Go to BioRestorative Therapies, Inc. Common Stock (NV) Website

$1.46

-0.02 (-1.34%)
Live
Previous Close

$1.48

Day Range

$1.4501 - $1.49

Previous Day Range

$1.4006 - $1.49

Market Cap

$10.6 million USD

Day Vol.

17967

Previous Day Vol.

27598

Currency

USD

Primary Exchange

Nasdaq

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

BioRestorative Therapies presented promising preliminary data from its ongoing Phase 2 clinical trial of BRTX-100, an autologous stem cell therapy for chronic lumbar disc disease. The data showed significant improvements in pain and function for a majority of subjects, with a favorable safety profile.

Related tickers: BRTX.

Read Full Article

BioRestorative Therapies, Inc. announced that it has changed the time for its previously announced webcasted conference call to discuss its pipeline update. The company will now host the call at 10:30am EST on Thursday, February 27, 2025.

Related tickers: BRTX.

Read Full Article
Trending Tickers

Please sign in to view